InnoPharmax Inc. (TPEX:4172)

Taiwan · Delayed Price · Currency is TWD

14.30

-0.15 (-1.04%)

May 8, 2026, 1:41 PM CST

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Design, Development, Production and Manufacturing of Pharmaceuticals	68.99M	32.30M	46.07M	29.13M	48.06M
Design, Development, Production and Manufacturing of Pharmaceuticals Growth	113.60%	-29.90%	58.15%	-39.38%	-64.89%
Total	68.99M	32.30M	46.07M	29.13M	48.06M
Total Growth	113.60%	-29.90%	58.15%	-39.38%	-64.89%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Taiwan	27.87M	23.38M	28.56M	29.13M	40.59M
Taiwan Growth	19.22%	-18.14%	-1.98%	-28.23%	10.50%
Mainland China	32.85M	8.92M	16.54M	-	3.58M
Mainland China Growth	268.36%	-46.07%	-	-	-96.32%
Others	8.26M	-	979.00K	-	3.89M
Others Growth	-	-	-	-	34.81%
Total	68.99M	32.30M	46.07M	29.13M	48.06M
Total Growth	113.60%	-29.90%	58.15%	-39.38%	-64.89%

Source: S&P Global Market Intelligence.